EQS-News: IBU-tec advanced materials AG Wins Asian Pharmaceutical Company as a New Major Customer

Corporate News

IBU-tec advanced materials AG Wins Asian Pharmaceutical Company as a New Major Customer

• Key substance for production of hypertension drug
• Expansion of IBU-tecs position in the healthcare sector
• Discussions with other potential customers well advanced
• IBU-tec Group sales to increase significantly to EUR 62-64 million in 2023 with double-digit EBITDA margin

Weimar, 22 May 2023 IBU-tec advanced materials AG (IBU-tec, ISIN: DE000A0XYHT5) is pleased to announce the acquisition of another major Asian pharmaceutical company as a new customer. The international generics manufacturer has now signed an initial contract for the supply of IBU-tecs product tributyltin chloride (TBTCl). The chemical catalyst is produced by the IBU-tec Group company BNT Chemicals in Bitterfeld and is used in the manufacture of blood pressure medication.

Thus, IBU-tec is further expanding its position as a supplier of high-quality catalysts for the pharmaceutical industry and has now gained its second major Asian customer for TBTCl. The total volume of the order is initially around 100 tons in the current year, with expected sales in the single-digit million Euro range.

The number of people worldwide suffering from hypertension is steadily increasing. By 2025, approximately 1.5 billion people will be affected. TBTCl is an important component in the chemical synthesis of drugs. IBU-tec is currently in advanced discussions with potential customers in the healthcare sector.

Jörg Leinenbach, CEO of IBU-tec: This order shows that quality made by IBU-tec is increasingly in demand worldwide. We offer our customers our own high-quality products with which they can produce sustainably and achieve competitive advantages in the global marketplace. This is what makes IBU-tec successful in all our business areas and is the engine of our growth. In the current year, we will significantly increase our sales from around EUR 54 million to EUR 62 to 64 million and achieve a double-digit EBITDA margin.

About IBU-tec

The IBU-tec Group develops and produces innovative materials of the highest quality for industry. It combines unique thermal process technology, some of which is patented, with the process and material know-how of around 250 highly qualified employees.

The companys own products include LFP battery material, which is an important component of batteries for electromobility and stationary energy storage, as well as solutions for air purification, resource conservation and the reduction of plastic packaging. IBU-tec is thus well positioned for the long term in global megatrends especially climate and environmental protection and has an international customer base ranging from innovative medium-sized companies to global corporations.

Contact

Investor Relations
IBU-tec advanced materials AG
Dr. Stefan Steck
Public & Investor Relations
Hainweg 9-11
99425 Weimar, Germany
t +49 3643 8649-51
IR@ibu-tec.de
www.ibu-tec.com

Financial and Business Press
edicto GmbH
Axel Mühlhaus
Eschersheimer Landstraße 42-44
60322 Frankfurt, Germany
t +49 69 905505-52
IBU-tec@edicto.de